• N-Formimidoyl Thienamycin: 1982 Antibacterial Study

  2026-08-28

  Cullmann and colleagues compared N-formimidoyl thienamycin with several contemporary β-lactam antibiotics across resistant clinical isolates and combined MIC testing with bactericidal and β-lactamase-related analyses. The study showed unusually broad gram-negative activity, especially against Pseudomonas aeruginosa and Acinetobacter spp., while also defining important species-specific limitations relative to cefotaxime and moxalactam.

• Cinoxacin In Vitro: Spectrum, Methods, and Resistance

  2026-08-28

  Lumish and Norden’s reference study established a systematic in vitro profile of Cinoxacin against clinical aerobic gram-negative isolates, combining MIC testing, disk diffusion, bactericidal assays, and serial-passage resistance experiments. Its findings defined strong activity against common urinary pathogens while identifying poor activity against Pseudomonas aeruginosa and gram-positive organisms and a substantial capacity for resistance selection.

• ADAMTS9-AS1, miR-587, and Ferroptosis in EOC

  2026-08-27

  The reference study identifies an ADAMTS9-AS1/miR-587/SLC7A11 regulatory axis that suppresses ferroptosis in epithelial ovarian cancer cells. Its combination of RNA perturbation, rescue experiments, and target-validation assays provides a mechanistic framework for linking non-coding RNA regulation with ferroptotic vulnerability in ovarian cancer.

• Doxycycline hyclate for BBB Research

  2026-08-27

  Doxycycline hyclate provides a practical way to interrogate MMP-2/MMP-9-driven blood-brain barrier injury, with a published mouse workflow linking intervention to tight-junction preservation and cognitive outcomes. This guide translates that evidence into assay design, formulation controls, cross-domain applications, and troubleshooting strategies for neurovascular and infection research.

• Amyloid β-Peptide (1-42): Applied Workflows

  2026-08-26

  Build reproducible Aβ42 models by separating peptide preparation, aggregation state, and biological readout. This workflow connects neuronal toxicity and ion-channel studies with a microglial clearance assay inspired by P2Y2 receptor biology.

• GI 254023X: Designing Better ADAM10 Assays

  2026-08-26

  GI 254023X is a selective ADAM10 inhibitor for separating proximal sheddase activity from downstream signaling and barrier phenotypes. This article combines ADAM10 biology with assay-design lessons from partial BACE inhibition to improve exposure, selectivity, and interpretation in preclinical models.

• Atorvastatin: From Mevalonate to Ferroptosis

  2026-08-25

  Atorvastatin is more than an HMG-CoA reductase inhibitor: it is a versatile probe for connecting cholesterol metabolism, vascular remodeling, and ferroptosis. This guide translates recent hepatocellular carcinoma findings into practical assay and model-selection decisions.

• Minocycline HCl as a Microglial Test of Translation

  2026-08-25

  Minocycline HCl can do more than suppress inflammation: used carefully, it can reveal whether microglial activity is required for stimulus-driven amyloid clearance. This translational perspective connects the 40-Hz retinal flicker findings with rigorous reagent selection, assay design, and development strategy.

• HMGB1 and Early Diabetic Nephropathy: Proteomic Evidence

  2026-08-24

  This iScience study combines quantitative serum proteomics, Mfuzz trajectory clustering, and WGCNA to identify proteins associated with diabetic nephropathy progression. HMGB1 was prioritized as a potential early-monitoring biomarker and was further supported by cell and animal experiments performed under high-glucose conditions, although prospective clinical validation remains necessary.

• CENPO, Prognosis, and Immunity in Lung Adenocarcinoma

  2026-08-24

  This study identifies CENPO as a superenhancer-associated oncogenic factor linked to poor prognosis, immune dysregulation, and aggressive behavior in lung adenocarcinoma. By integrating TCGA and GEO analyses with chromatin visualization and cell-based validation, it proposes the CENPO-associated prognostic signature as a potentially useful framework for risk stratification and mechanistic studies.

• Wnt agonist 1 in Wnt–GPX4 Assay Design

  2026-08-23

  Wnt agonist 1 (BML-284) offers a defined pharmacological input for studying β-catenin–TCF signaling and its possible relationship to GPX4-linked platinum resistance. This article focuses on causal assay design, evidence boundaries, and translational limitations rather than repeating a standard activation protocol.

• 40-Hz Flicker and Retinal Amyloid Clearance

  2026-08-22

  A 2026 mouse study reports that 40-Hz light flicker enhances retinal amyloid-β clearance through regulation of MHC-II-positive microglia. The work connects sensory stimulation with immune-mediated waste removal and uses minocycline inhibition to test whether microglial activity is required for improved retinal function.

• Tetracycline: From Ribosome Tool to Translation

  2026-08-21

  Tetracycline is more than a routine antibiotic selection reagent. This thought-leadership article examines its ribosomal mechanism, experimental value, translational boundaries, and strategic use alongside mechanistic cancer research such as LKB1-driven senescence in lung adenocarcinoma.

• Fingolimod and the Next Frontier of Immune Trafficking

  2026-08-20

  Fingolimod (FTY720) offers translational researchers more than an established multiple sclerosis mechanism: it is a controlled perturbation of lymphocyte positioning. When considered alongside magnetic bispecific nano-antibody platforms for in vivo CAR-T-mimicking cell generation, its value lies in helping researchers separate immune-cell availability, tumor infiltration, and per-cell antitumor function.

• Cyclosporin A: From Mechanism to Translation

  2026-08-20

  Cyclosporin A is more than a calcineurin inhibitor. Its cyclophilin-dependent biology, membrane behavior, and variant-specific mitochondrial activity provide a practical framework for designing more predictive immunology and mitochondrial studies.

8423 records 1/562 page Next 12345 下5页 Last page